Acasti Pharma Inc - Rasio cepet ACST

The Acasti Pharma (ACST) price chart demonstrates the dynamics of an asset with a coefficient of 7.73. Acasti Pharma develops advanced therapies for orphan diseases, focusing on optimizing drug delivery methods. The business relies on strict supply chain management for hospitals and a network of contract manufacturing organizations to protect margins. Current growth potential is tied to the patent protection of transmucosal systems and FDA approval.

Acasti Pharma (ACST) relies on proprietary protection of drug delivery systems to ensure high margins. The quick ratio reflects the company's ability to meet short-term obligations using cash and accounts receivable, completely excluding slow-moving inventories. This trend captures the balance sheet's actual resilience in the event of sudden financial shocks. This indicator determines the issuer's investment stability during the innovation development period.